Literature DB >> 13233043

Ergotamine tolerance in patients with migraine.

A P FRIEDMAN, T J VON STORCH.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS/therapeutic use; MIGRAINE/therapy

Mesh：

Substances：

Year:  1955        PMID： 13233043     DOI： 10.1001/jama.1955.02950280005002

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  9 in total

1.  PROLONGED ARTERIOSPASM AFTER OVERDOSE OF ORAL ERGOTAMINE TARTRATE IN MIGRAINE.

Authors:  E BYRNE-QUINN
Journal:  Br Med J       Date:  1964-08-29

2.  Psychosis with Vicks Formula 44-D abuse.

Authors:  D F Craig
Journal:  CMAJ       Date:  1992-04-01       Impact factor: 8.262

Review 3.  [Vasoactive substances belonging to the body and pharmacologic agents with peripheral point of application].

Authors:  E Muscholl
Journal:  Arch Klin Exp Ohren Nasen Kehlkopfheilkd       Date:  1967

4.  Systemic availability of ergotamine tartrate after three successive doses and during continuous medication.

Authors:  V Ala-Hurula; V V Myllylä; P Arvela; N T Kärki; E Hokkanen
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

5.  Ergot poisoning.

Authors:  G Glazer; K A Myers; E R Davies
Journal:  Postgrad Med J       Date:  1966-09       Impact factor: 2.401

6.  Chronic Daily Headache.

Authors:  James R. Couch
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

7.  Abuse and paradoxical effects of analgesic drug mixtures.

Authors:  R Wörz
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 8.  The long-term prognosis of tension-type headache.

Authors:  James R Couch
Journal:  Curr Pain Headache Rep       Date:  2005-12

Review 9.  Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Authors:  Nicolas Vandenbussche; Domenico Laterza; Marco Lisicki; Joseph Lloyd; Chiara Lupi; Hannes Tischler; Kati Toom; Fenne Vandervorst; Simone Quintana; Koen Paemeleire; Zaza Katsarava
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.